BACKGROUND: Rodent models as well as studies in humans have suggested alterations in serotonin (5-HT) innervation and transmission in early-onset genetically determined or type II alcoholism. This study examines two indices of serotonergic transmission, 5-HT transporter levels and 5-HT(1A) availability, in vivo, in type II alcoholism. This is the first report of combined tracers for pre- and postsynaptic serotonergic transmission in the same alcoholic subjects and the first study of 5-HT(1A) receptors in alcoholism. METHODS: Fourteen alcohol-dependent subjects were scanned (11 with both tracers, 1 with [(11)C]DASB only, and two with [(11)C]WAY100635 only). Twelve healthy control subjects (HC) subjects were scanned with [(11)C]DASB, and another 13 were scanned with [(11)C]WAY100635. Binding potential (BP(p), mL/cm(3)) and the specific to nonspecific partition coefficient (BP(ND), unitless) were derived for both tracers using a two-tissue compartment model and compared with control subjects across different brain regions. Relationships to severity of alcoholism were assessed. RESULTS: No significant differences were observed in regional BP(p) or BP(ND) between patients and control subjects in any of the regions examined. No significant relationships were observed between regional 5-HT transporter availability, 5-HT(1A) availability, and disease severity, with the exception of a significant negative correlation between 5-HT transporters and years of dependence in amygdala and insula. CONCLUSION: This study did not find alterations in measures of 5-HT(1A) or 5-HT transporter levels in patients with type II alcoholism.
BACKGROUND: Rodent models as well as studies in humans have suggested alterations in serotonin (5-HT) innervation and transmission in early-onset genetically determined or type II alcoholism. This study examines two indices of serotonergic transmission, 5-HT transporter levels and 5-HT(1A) availability, in vivo, in type II alcoholism. This is the first report of combined tracers for pre- and postsynaptic serotonergic transmission in the same alcoholic subjects and the first study of 5-HT(1A) receptors in alcoholism. METHODS: Fourteen alcohol-dependent subjects were scanned (11 with both tracers, 1 with [(11)C]DASB only, and two with [(11)C]WAY100635 only). Twelve healthy control subjects (HC) subjects were scanned with [(11)C]DASB, and another 13 were scanned with [(11)C]WAY100635. Binding potential (BP(p), mL/cm(3)) and the specific to nonspecific partition coefficient (BP(ND), unitless) were derived for both tracers using a two-tissue compartment model and compared with control subjects across different brain regions. Relationships to severity of alcoholism were assessed. RESULTS: No significant differences were observed in regional BP(p) or BP(ND) between patients and control subjects in any of the regions examined. No significant relationships were observed between regional 5-HT transporter availability, 5-HT(1A) availability, and disease severity, with the exception of a significant negative correlation between 5-HT transporters and years of dependence in amygdala and insula. CONCLUSION: This study did not find alterations in measures of 5-HT(1A) or 5-HT transporter levels in patients with type II alcoholism.
Authors: M Reimold; M N Smolka; G Schumann; A Zimmer; J Wrase; K Mann; X-Z Hu; D Goldman; G Reischl; C Solbach; H-J Machulla; R Bares; A Heinz Journal: J Neural Transm (Vienna) Date: 2007-01-18 Impact factor: 3.575
Authors: Amira K Brown; David T George; Masahiro Fujita; Jeih-San Liow; Masanori Ichise; Joseph Hibbeln; Subroto Ghose; Janet Sangare; Daniel Hommer; Robert B Innis Journal: Alcohol Clin Exp Res Date: 2007-01 Impact factor: 3.455
Authors: Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson Journal: J Cereb Blood Flow Metab Date: 2007-05-09 Impact factor: 6.200
Authors: Jian Hu; Shannan Henry; Jean-Dominique Gallezot; Jim Ropchan; John F Neumaier; Marc N Potenza; Rajita Sinha; John H Krystal; Yiyun Huang; Yu-Shin Ding; Richard E Carson; Alexander Neumeister Journal: Biol Psychiatry Date: 2010-02-20 Impact factor: 13.382
Authors: Nina Bl Urban; Ragy R Girgis; Peter S Talbot; Lawrence S Kegeles; X Xu; W Gordon Frankle; Carl L Hart; Mark Slifstein; Anissa Abi-Dargham; Marc Laruelle Journal: Neuropsychopharmacology Date: 2012-02-22 Impact factor: 7.853
Authors: Elizabeth J Burnett; Kathleen A Grant; April T Davenport; Scott E Hemby; David P Friedman Journal: Drug Alcohol Depend Date: 2014-01-15 Impact factor: 4.492
Authors: Brittany A Matthews; Stephen J Kish; Xin Xu; Isabelle Boileau; Pablo M Rusjan; Alan A Wilson; Dan DiGiacomo; Sylvain Houle; Jeffrey H Meyer Journal: Biol Psychiatry Date: 2013-10-12 Impact factor: 13.382
Authors: Ansel T Hillmer; Dustin W Wooten; Dana L Tudorascu; Todd E Barnhart; Elizabeth O Ahlers; Leslie M Resch; Julie A Larson; Alexander K Converse; Colleen F Moore; Mary L Schneider; Bradley T Christian Journal: Drug Alcohol Depend Date: 2014-08-29 Impact factor: 4.492